Search

Your search keyword '"Heytens, Stefan"' showing total 9 results
Start Over Author "Heytens, Stefan" Publisher bmj
9 results on '"Heytens, Stefan"'

2. Validation of a rapid SARS-CoV-2 antibody test in general practice

Author

Domen, Julie, primary, Verbakel, Jan Yvan Jos, additional, Adriaenssens, Niels, additional, Scholtes, Beatrice, additional, Peeters, Bart, additional, Bruyndonckx, Robin, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laetitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2023
Full Text
View/download PDF

4. Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Van Ngoc, Pauline, additional, Verbakel, Jan Yvan Jos, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van Den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laetitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2022
Full Text
View/download PDF

7. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Author

Adriaenssens, Niels, primary, Scholtes, Beatrice, additional, Bruyndonckx, Robin, additional, Verbakel, Jan Y, additional, De Sutter, An, additional, Heytens, Stefan, additional, Van den Bruel, Ann, additional, Desombere, Isabelle, additional, Van Damme, Pierre, additional, Goossens, Herman, additional, Buret, Laëtitia, additional, Duysburgh, Els, additional, and Coenen, Samuel, additional

Published
2022
Full Text
View/download PDF

8. Strategies to reduce antibiotic use in women with uncomplicated urinary tract infection in primary care: protocol of a systematic review and meta-analysis including individual patient data

Author

Heinz, Judith, primary, Röver, Christian, additional, Furaijat, Ghefar, additional, Kaußner, Yvonne, additional, Hummers, Eva, additional, Debray, Thomas, additional, Hay, Alastair D, additional, Heytens, Stefan, additional, Vik, Ingvild, additional, Little, Paul, additional, Moore, Michael, additional, Stuart, Beth, additional, Wagenlehner, Florian, additional, Kronenberg, Andreas, additional, Ferry, Sven, additional, Monsen, Tor, additional, Lindbaek, Morten, additional, Friede, Tim, additional, and Gagyor, Ildiko, additional

Published
2020
Full Text
View/download PDF

9. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Author

Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, Jan Y Verbakel, An De Sutter, Stefan Heytens, Ann Van den Bruel, Isabelle Desombere, Pierre Van Damme, Herman Goossens, Laëtitia Buret, Els Duysburgh, Samuel Coenen, Adriaenssens, Niels/0000-0002-7957-1177, Bruyndonckx, Robin/0000-0002-4217-2869, Verbakel, Jan/0000-0002-7166-7211, Adriaenssens, Niels, Scholtes, Beatrice, BRUYNDONCKX, Robin, Verbakel, Jan Y., De Sutter, An, Heytens, Stefan, van den Bruel , Ann, Desombere, Isabelle, van Damme , Pierre, Goossens, Herman, Buret, Laetitia, Duysburgh, Els, and Coenen , Samuel

Subjects
SARS-CoV-2, Health Personnel, Incidence, public health, COVID-19, General Medicine, Cohort Studies, primary care, Belgium, Seroepidemiologic Studies, general medicine (see internal medicine), Prevalence, Medicine, Humans, Prospective Studies, Human medicine, General practice / Family practice
Abstract

IntroductionNational SARS-CoV-2 seroprevalence data provide essential information about population exposure to the virus and help predict the future course of the epidemic. Early cohort studies have suggested declines in levels of antibodies in individuals associated with, for example, illness severity, age and comorbidities. This protocol focuses on the seroprevalence among primary healthcare providers (PHCPs) in Belgium. PHCPs manage the vast majority of (COVID-19) patients and therefore play an essential role in the efficient organisation of healthcare. Currently, evidence is lacking on (1) how many PHCPs get infected with SARS-CoV-2 in Belgium, (2) the rate at which this happens, (3) their clinical spectrum, (4) their risk factors, (5) the effectiveness of the measures to prevent infection and (6) the accuracy of the serology-based point-of-care test (POCT) in a primary care setting.Methods and analysisThis study will be set up as a prospective cohort study. General practitioners (GPs) and other PHCPs (working in a GP practice) will be recruited via professional networks and professional media outlets to register online to participate. Registered GPs and other PHCPs will be asked at each testing point (n=9) to perform a capillary blood sample antibody POCT targeting IgM and IgG against the receptor-binding domain of SARS-CoV-2 and complete an online questionnaire. The primary outcomes are the prevalence and incidence of antibodies against SARS-CoV-2 in PHCPs during a 12-month follow-up period. Secondary outcomes include the longevity of antibodies against SARS-CoV-2.Ethics and disseminationEthical approval has been granted by the ethics committee of the University Hospital of Antwerp/University of Antwerp (Belgian registration number: 3002020000237). Alongside journal publications, dissemination activities include the publication of monthly reports to be shared with the participants and the general population through the publicly available website of the Belgian health authorities (Sciensano).Trial registration numberNCT04779424.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results